Search - tctmd.com

Displaying 41 - 60 of 291

Sort: Relevancy | Date

News Conference News ESC 2024

OCCUPI: OCT Guidance Improves Outcomes in Complex PCI

Shelley Wood

September 03, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

News Daily News

Certain Periprocedural MIs Don’t Matter, New Data Allege

Michael O'Riordan

May 09, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

L.A. McKeown

March 20, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Caitlin E. Cox

February 09, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Advertisement

OCCUPI: OCT Guidance Improves Outcomes in Complex PCI

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

With ANOCA, Better to Test Coronary Function in Multiple Vessels

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Certain Periprocedural MIs Don’t Matter, New Data Allege

FDA Approves Bioresorbable Scaffold for BTK Lesions

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

April 2024 Dispatch for the CV Team

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

January 2024 Dispatch for the CV Team

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content